ALFA Filings
Every announcement, straight from the exchange
Every Jubilant Pharmova results update announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements with these filters
Jubilant Pharmova reported Q1 FY27 revenue of ₹2,229 Crore, reflecting 17% YoY growth. Net profit stood at ₹56 Crore amidst margin impacts.
Jubilant Pharmova reported FY26 revenue of ₹8,280 Crore, a 14% YoY increase. Growth was driven by the CDMO Sterile Injectables segment and expanded Ruby-Fill® installations.